Abstract
BackgroundTriple-negative breast cancer (TNBC) poses unique challenges due to its complex nature and the need for more effective treatments. Recent studies showed encouraging outcomes from combining paclitaxel (PTX) with programmed...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have